Dongli Meng

Xinxiang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Insights into the role of the mechanosensitive Piezo1 channel and signaling mechanisms in CNS functions and diseases.

Insights into the role of the mechanosensitive Piezo1 channel and signaling mechanisms in CNS functions and diseases.

Journal: Neuroscience and biobehavioral reviews

Published: November 23, 2025

Helicobacter pylori outer membrane vesicles directly promote Aβ aggregation and enhance Aβ toxicity in APP/PS1 mice.

Helicobacter pylori outer membrane vesicles directly promote Aβ aggregation and enhance Aβ toxicity in APP/PS1 mice.

Journal: Communications biology

Published: April 24, 2024

Tau induces inflammasome activation and microgliosis through acetylating NLRP3.

Tau induces inflammasome activation and microgliosis through acetylating NLRP3.

Journal: Clinical and translational medicine

Published: November 01, 2023

Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.

Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer's disease-like neuropathology and cognitive deficits.

Journal: Aging

Published: August 16, 2023

Microglia activation mediates circadian rhythm disruption-induced cognitive impairment in mice.

Microglia activation mediates circadian rhythm disruption-induced cognitive impairment in mice.

Journal: Journal of neuroimmunology

Published: December 22, 2022

Rifaximin protects against circadian rhythm disruption-induced cognitive impairment through preventing gut barrier damage and neuroinflammation.

Rifaximin protects against circadian rhythm disruption-induced cognitive impairment through preventing gut barrier damage and neuroinflammation.

Journal: Journal of neurochemistry

Published: June 17, 2022

Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.

Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: February 15, 2022

FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro.

FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro.

Journal: Neuroscience letters

Published: April 01, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026